Open AccessSystemic Immune-Inflammation Index Predicts 3-Month Functional Outcome in Acute Ischemic Stroke Patients Treated with Intravenous Thrombolysis
Author(s) -
Yiyun Weng,
Tian Zeng,
Honghao Huang,
Jinhan Ren,
Jianbo Wang,
Chenguang Yang,
Wenjing Pan,
Jingyu Hu,
Fangyue Sun,
Xinbo Zhou,
Haojie Qiu,
Yufan Gao,
Beibei Gao,
Lifen Chi,
Guangyong Chen
Publication year - 2021
Publication title -
clinical interventions in aging
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.184
H-Index - 76
eISSN - 1178-1998
pISSN - 1176-9092
DOI - 10.2147/cia.s311047
Subject(s) - medicine , modified rankin scale , thrombolysis , logistic regression , stroke (engine) , biomarker , gastroenterology , ischemic stroke , ischemia , myocardial infarction , mechanical engineering , biochemistry , chemistry , engineering
Systemic immune-inflammation index (SII), a novel inflammation index derived from counts of circulating platelets, neutrophils and lymphocytes, has been studied in developing incident cancer. However, the clinical value of SII in acute ischemic stroke (AIS) patients had not been further investigated. Therefore, we aimed to explore the association between SII and severity of stroke as well as 3-month outcome of AIS patients.